New study finds Trump-touted hydroxychloroquine does not benefit coronavirus patients
A nationwide study that's been submitted to the New England Journal of Medicine found that hydroxychloroquine — a malaria drug often touted by President Trump has a strong candidate for COVID-19 therapy — does not benefit coronavirus patients, The Associated Press reports.
In fact, the analysis, which tracked 368 patients in U.S. veterans hospitals, shows that patients treated with the drug actually died at a higher rate than those treated with standard care. Hydroxychloroquine reportedly also didn't make a difference when it comes to who needed a breathing machine.
The study was the largest to look at the drug so far, but like its predecessors, it still isn't considered a rigorous experiment and has yet to be peer-reviewed. The National Institutes of Health and other research labs are in the process of conducting large-scale trials that will hopefully paint a clear picture of its efficacy. Still, several scientists have been "underwhelmed" with the drug's performance so far. Read more at The Associated Press.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Congress reaches spending deal to avert shutdown
Speed Read The bill would fund the government through March 14, 2025
By Peter Weber, The Week US Published
-
Luigi Mangione charged with murder, terrorism
Speed Read Magnione is accused of murdering UnitedHealthcare CEO Brian Thompson
By Peter Weber, The Week US Published
-
Ex-FBI informant pleads guilty to lying about Bidens
Speed Read Alexander Smirnov claimed that President Joe Biden and his son Hunter were involved in a bribery scheme with Ukrainian energy company Burisma
By Rafi Schwartz, The Week US Published
-
South Korea impeaches president, eyes charges
Speed Read Yoon Suk Yeol faces investigations on potential insurrection and abuse of power charges
By Peter Weber, The Week US Published
-
Biden sets new clemency record, hints at more
Speed Read President Joe Biden commuted a record 1,499 sentences and pardoned 39 others convicted of nonviolent crimes
By Rafi Schwartz, The Week US Published
-
Mysterious drones roil New Jersey, prompt FBI inquiry
Speed Read State and federal officials are both stumped and concerned
By Peter Weber, The Week US Published
-
South Korean president vows to fight removal
Speed Read Yoon Suk Yeol defended his martial law decree and said he will not step down, despite impeachment efforts
By Peter Weber, The Week US Published
-
FBI Director Christopher Wray to step down for Trump
speed read The president-elect had vowed to fire Wray so he could install loyalist Kash Patel
By Rafi Schwartz, The Week US Published